Intellia Therapeutics Inc buy melinda
Start price
08.03.18
/
50%
€28.31
Target price
10.09.18
€68.55
Performance (%)
-13.22%
End price
10.09.18
€24.57
Summary
This prediction ended on 10.09.18 with a price of €24.57. The prediction for Intellia Therapeutics Inc disappointed with a performance of -13.22%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Intellia Therapeutics Inc | -7.046% | -7.046% | -34.752% | -78.204% |
| iShares Core DAX® | -0.793% | 4.201% | 19.951% | 70.602% |
| iShares Nasdaq 100 | -2.376% | 0.857% | 4.704% | 103.322% |
| iShares Nikkei 225® | -2.701% | -0.147% | 12.609% | 44.593% |
| iShares S&P 500 | -1.689% | 1.244% | 3.144% | 64.741% |
According to melinda what are the pros and cons of Intellia Therapeutics Inc for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Biotechnologie und Medizintechnik SecteurRecherche Agenda 13/03 | 20.50 Präsentation
mehr
$ NTLA mit einem Outperform bei JMP Initiiert & $ 76 PT
(Laufzeit überschritten)
Stopped prediction by melinda for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€18.68
21.05.20
21.05.20
€30.00
04.11.21
04.11.21
531.06%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
